SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aspira Pathlab & Diagnostics informs about closure of trading window

28 Dec 2023 Evaluate
Aspira Pathlab & Diagnostics has informed that pursuant to the Securities & Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 read with the Company Code of Conduct for Prevention of Insider Trading the ‘Trading Window’ for dealing with equity shares of the Company will remain closed for Designated Persons of the Company covered under the code with effect from Monday, January 01, 2024 and will re-open 48 hours after the unaudited financial results are communicated to Stock Exchange for the third quarter and nine months period ended December 31, 2023.

The above information is a part of company’s filings submitted to BSE.

Aspira Pathlab&Diagn Share Price

59.35 1.15 (1.98%)
17-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×